Human Matrix Gla protein Recombinant Protein Product Attributes
Product Type: Recombinant Protein
Recombinant Matrix Gla protein based upon sequence from Human
Host: QP6359 protein expressed in E. coli.
Tag: His
Protein Construction: A DNA sequence encoding the Homo sapiens (Human) Matrix Gla protein, was expressed in the hosts and tags indicated. Please select your host/tag option, above.
Recommended Applications: Immunogen, Protein Standard, Cell culture, or Other Cell Biology Applications.
Application Notes: Please contact us for application specific information for QP6359.
Bioactivity Data: Untested
Full Length? Full Length
Expression Region: Tyr20 – Phe96
Amino Acid Sequence: YESHESMESY ELNPFINRRN ANTFISPQQR WRAKVQERIR ERSKPVHELN REACDDYRLC ERYAMVYGYN AAYNRYF
Purity: Greater than 90% as determined by SDS-PAGE.
Reconstitution Instructions: Concentrated protein in liquid format. Reconstitution is not necessary.
Concentration of Human Matrix Gla protein Protein:
Endotoxin Levels: Not determined.
Buffer: Tris-based buffer, 50% glycerol
Storage Conditions: Store at -20C to -80C.
Recombinant Human Matrix Gla protein Protein General Information | |
---|---|
Alternate Names | |
NTI, GIG36, MGLAP | |
Curated Database and Bioinformatic Data | |
Gene Symbol | Mgp |
Entrez Gene ID | 4256 |
Ensemble Gene ID | ENSG00000111341 |
RefSeq Protein Accession(s) | NP_000891.2 |
RefSeq mRNA Accession(s) | NM_000900.4, NM_001190839.2 |
UniProt ID(s) | P08493 |
UniGene ID(s) | Hs.365706 |
HGNC ID(s) | HGNC:7060 |
COSMIC ID Link(s) | Mgp |
KEGG Gene ID(s) | hsa:4256 |
PharmGKB ID(s) | PA30790 |
General Description of Recombinant Human Matrix Gla protein Protein. | |
Associates with the organic matrix of bone and cartilage. Thought to act as an inhibitor of bone formation. |
Limitations and Performance Guarantee
This is a life science research product (for Research Use Only). This product is guaranteed to work for a period of two years when stored at -70C or colder, and one year when aliquoted and stored at -20C.
There are no reviews yet.